Formation of Provider Network Holdings Unites Altus Biologics, Remedy GPO, Cornerstone Specialty Network, and Health Coalition to Empower Specialty Providers and Supply Chain Stakeholders
Formation of Provider Network Holdings Unites Altus Biologics, Remedy GPO, Cornerstone Specialty Network, and Health Coalition to Empower Specialty Providers and Supply Chain Stakeholders
The formation of PNH extends the breadth of ways each organization can service clients while also providing a meaningful opportunity to enter adjacent therapeutic areas in the $300B+ specialty medication market.PEARLAND, Texas, April 10, 2024 /PRNewswire/ -- The formation of Provider Network Holdings ("PNH") was announced today through the partnership and combination of Altus Biologics ("Altus"), Remedy GPO ("Remedy"), Cornerstone Specialty Network ("Cornerstone"), and Health Coalition Inc. ("Health Coalition"). The combination enables the new platform to reach a broader network of specialty providers across community-based oncology, neurology, rheumatology, gastroenterology, allergy, immunology, pulmonary, and infectious disease practices. These four innovative and market leading organizations are committed to the mission of supporting independent specialty practices and providers throughout the country with technology, tools and services for specialty and biologic drug purchasing, supply chain, revenue cycle management, education, and research. Together, the combined organization will support over 1,500 physicians across 41 states.
得克薩斯州皮爾蘭，2024年4月10日 /PRNewswire/ — 今天宣佈通過Altus Biologics（“Altus”）、Remedy GPO（“Remedy”）、Cornerstone Specialty Network（“Cornerstone”）和健康聯盟公司（“健康聯盟”）的合作和合並，成立提供商網絡控股公司（“PNH”）。此次合併使新平台能夠覆蓋更廣泛的專業提供者網絡，涵蓋社區腫瘤學、神經病學、風溼病學、胃腸病學、過敏、免疫學、肺部和傳染病診所。這四個具有創新精神和市場領先地位的組織致力於爲全國各地的獨立專業診所和提供商提供支持，爲特種和生物藥物採購、供應鏈、收入週期管理、教育和研究提供商提供技術、工具和服務。合併後的組織將共同爲41個州的1,500多名醫生提供支持。
Altus is a leading provider of comprehensive supply chain services for biologic and specialty medication management, as well as in-office infusion management services. Remedy operates a group purchasing organization and offers value-added services that are responsive to both specialty providers and pharmaceutical partners' needs. Cornerstone is the largest independent community oncology network, delivering aggregated value-based offerings, educational resources, research, and data services. Health Coalition is a specialty and biologic pharmaceutical distributor with value-added capabilities serving manufacturers and providers. Together with the backing of Waud Capital Partners ("WCP"), a healthcare-focused private equity firm, PNH will offer a continuum of essential and differentiated products and solutions for a variety of specialty and biologic drug needs. PNH will also serve as a value-add partner to pharmaceutical manufacturers and wholesalers, while also working to build a broader suite of supply chain services and improve provider engagement.
Altus 是生物製劑和特種藥物管理綜合供應鏈服務以及辦公室內輸液管理服務的領先提供商。Remedy 經營團體採購組織，提供增值服務，以滿足專業提供商和製藥合作伙伴的需求。Cornerstone是最大的獨立社區腫瘤學網絡，提供基於價值的綜合產品、教育資源、研究和數據服務。Health Coalition是一家專業和生物製藥分銷商，具有爲製造商和提供商提供服務的增值能力。在專注於醫療保健的私募股權公司Waud Capital Partners（“WCP”）的支持下，PNH將爲各種特種和生物藥物需求提供一系列基本和差異化的產品和解決方案。PNH還將成爲藥品製造商和批發商的增值合作伙伴，同時還將努力建立更廣泛的供應鏈服務並提高提供商的參與度。
David Lowenberg, Chairman of PNH and WCP Operating Partner, expressed enthusiasm about the combination of Altus, Remedy, Cornerstone, and Health Coalition within PNH. He commented, "We are pleased to unite these four highly valuable organizations, aligning our commitment to bolster value-added performance and enhance efficiency. This confluence of tailored offerings for the distinctive challenges faced by physician practices and providers creates an end-to-end solutions provider for the specialty and biologic drug market."
PNH主席兼WCP運營合作伙伴大衛·洛文伯格對PNH內部Altus、Remedy、Cornerstone和Health Coalition的合併表示熱情。他評論說：“我們很高興將這四個極具價值的組織聯合起來，協調我們對提高增值績效和提高效率的承諾。這種針對醫生診所和提供商面臨的獨特挑戰的量身定製產品的融合爲特種和生物藥物市場創造了端到端的解決方案提供商。”
The formation of PNH extends the breadth of ways each organization can service clients while also providing a meaningful opportunity to enter adjacent therapeutic areas in the $300B+ specialty medication market.
PNH的成立擴大了每個組織爲客戶提供服務的方式的廣度，同時也爲進入3000億美元以上的特種藥物市場中的鄰近治療領域提供了有意義的機會。
"We built Cornerstone to empower practices with the advantages of scale while protecting their independence and fuel meaningful customer engagement for our manufacturer partners," said Joel Schaedler, CEO of Cornerstone, who will continue leading the business as part of PNH. "I am excited to thoughtfully expand the relevant portfolio of services we can offer to our diversified, purpose-built network as part of Provider Network Holdings."
作爲PNH的一部分，Cornerstone首席執行官喬爾·舍德勒表示：“我們建立Cornerstone的目的是讓業務部門發揮規模優勢，同時保護其獨立性，促進製造商合作伙伴的有意義的客戶參與。”“作爲提供商網絡控股的一部分，我很高興能夠深思熟慮地擴大我們可以爲我們的多元化、專門構建的網絡提供的相關服務組合。”
Walter Shikany III, President of Health Coalition, commented, "Health Coalition partners with specialty pharmaceutical manufacturers to educate, distribute, and service an expansive and decentralized network of providers requiring a high-touch approach. We are thrilled for this next chapter in Health Coalition's over 35 years of finding the best solutions for the unique challenges each practice faces."
健康聯盟主席沃爾特·希卡尼三世評論說：“健康聯盟與特種藥品製造商合作，對需要高接觸方法的龐大而分散的提供商網絡進行教育、分銷和服務。我們對健康聯盟35年來爲每家診所面臨的獨特挑戰尋找最佳解決方案的下一個篇章感到非常興奮。”
About Provider Network Holdings
關於提供商網絡控股
Provider Network Holdings supports a deep network of over 1,500 provider partners across multiple physician specialties with a comprehensive suite of practice management, supply chain, group purchasing, and pharmaceutical solutions for specialty and biologic drug needs. Proprietary technology, data analytics, and unique clinical positioning enable Provider Network Holdings to create custom programs and breakthrough offerings that address the evolving landscape across specialty providers, pharmaceutical manufacturers, and wholesalers. To learn more, visit .
Provider Network Holdings爲涵蓋多個醫師專業的1,500多家提供商合作伙伴的深度網絡提供支持，爲滿足特種和生物藥物需求的全套執業管理、供應鏈、團體採購和藥物解決方案提供支持。專有技術、數據分析和獨特的臨床定位使Provider Network Holdings能夠創建定製計劃和突破性產品，以應對專業提供商、藥品製造商和批發商不斷變化的格局。要了解更多信息，請訪問。
About Waud Capital Partners
關於沃德資本合夥人
Based in Chicago, Waud Capital Partners ("WCP") is a growth-oriented private equity firm with over 30 years of investing experience. WCP seeks to partner with experienced management teams to build market-leading companies within two industries: healthcare and software & technology. Since its founding in 1993, WCP has successfully completed more than 460 investments, including platform companies and follow-on opportunities. For additional information on WCP, please visit .
Waud Capital Partners（“WCP”）總部位於芝加哥，是一家以增長爲導向的私募股權公司，擁有超過30年的投資經驗。WCP尋求與經驗豐富的管理團隊合作，在兩個行業中建立市場領先的公司：醫療保健和軟件與技術。自1993年成立以來，WCP已成功完成了460多項投資，包括平台公司和後續機會。有關 WCP 的更多信息，請訪問。
Provider Network Holdings Contact:
[email protected]
提供商網絡控股聯繫人：
[電子郵件保護]
WCP Investment Professional Contact:
Tim Cremieux, Principal
[email protected]
WCP 投資專業人員聯繫方式：
蒂姆·克雷米厄斯，校長
[電子郵件保護]
WCP Business Development Contact:
Phil Olson, Partner
[email protected]
WCP 業務開發聯繫人：
菲爾·奧爾森，合夥人
[電子郵件保護]
WCP Investor Relations Contact:
Matt Albers, Partner
[email protected]
WCP 投資者關係聯繫人：
馬特·阿爾伯斯，合夥人
[電子郵件保護]
SOURCE Waud Capital Partners
來源沃德資本合夥人
